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Environments of the Four Tryptophans in the Extracellular Domain of
Human Tissue Factor: Comparison of Results from Absorption and
Fluorescence Difference Spectra of Tryptophan Replacement Mutants
with the Crystal Structure of the Wild-Type Protein
C. A. Hasselbacher,* E. Rusinova,* E. Waxman,* R. Rusinova,* R. A. Kohanski,* W. Lam,* A. Guha,$ J.
T. C. Lin,§ 1. Polikarpov,11 C. W. G. Boys,11 Y. Nemerson,*t W. H. Konigsberg,§ and J. B. A. Ross*

Du,§

Departments of *Biochemistry and *Medicine, Mount Sinai School of Medicine, New York, New York 10029, and §Department of
Biochemistry, Yale University, New Haven, Connecticut 06510 USA; and 'IDepartment of Biochemistry, The Medical School, Edinburgh
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ABSTRACT The local environments of the four tryptophan residues of the extracellular domain of human tissue factor (sTF)
were assessed from difference absorption and fluorescence spectra. The difference spectra were derived by subtracting
spectra from single Trp-to-Phe or Trp-to-Tyr replacement mutants from the corresponding spectrum of the wild-type protein.
Each of the mutants was capable of enhancing the proteolytic activity of factor Vila showing that the mutations did not
introduce major structural changes, although the mutants were more susceptible to denaturation by guanidinium chloride.
The difference spectra indicate that the Trp residues are buried to different extents within the protein matrix. This evaluation
was compared with the x-ray crystal structure of sTF. There is excellent agreement between predictions from the difference
spectra and the environments of the Trp residues observed in the x-ray crystal structure, demonstrating that difference
absorption and particularly fluorescence spectra derived from functional single-Trp replacement mutants can be used to
obtain information about the local environments of individual Trp residues in multi-tryptophan proteins.

INTRODUCTION
The absorbance and fluorescence characteristics of tryptophan residues provide direct information about the chemical
nature of the local environment surrounding the indole side
chain. Specifically, the sensitivity of the fluorescence spectrum, emission intensity, lifetime, and anisotropy to the
local environment makes Trp spectra invaluable tools for
probing conformational change. An extensive literature has
been established recently in which intrinsic fluorescence is
used to analyze Trp environments of single-Trp proteins
that occur naturally or are created by recombinant genetic
techniques. Because of the obvious difficulties in resolving
fluorescence signals from multiple, similar fluorophores, it
is difficult to obtain information that is as detailed from the
more commonly occurring proteins that contain several Trp
residues.
One approach to simplify spectral analysis is to generate
amino acid replacements of all but one Trp residue with the
anticipation that the resulting absorption and fluorescence
will be characteristic of that single Trp residue as it behaved
in the original wild-type protein. Not surprisingly, however,
simultaneous replacement of several residues often results
in failure of protein expression or in expression of mutant
proteins that are nonfunctional or conformationally nonrepresentative of the parent molecule. To minimize these perReceivedfor publication 23 January 1995 and in final form 4 April 1995.
Address reprint requests to Dr. J. B. Alexander Ross, Department of
Biochemistry, Mount Sinai School of Medicine, Box 1020, One Gustave L.
Levy Place, New York, NY 10029-0574. Tel. 212-241-5569; Fax: 212996-7214; E-mail: sross@smtplink.mssm.edu.
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0006-3495/95/07/20/10 $2.00

turbations, we have taken a more conservative approach in
which individual Trp residues in a multi-Trp protein are
replaced one at a time with either Phe or Tyr, systematically
generating a panel of mutants that have one fewer Trp than
the parent protein. Then the absorbance and fluorescence
spectra of the eliminated Trp are obtained by the difference
between the mutant and wild-type protein spectra. This
latter strategy is based on the assumption that replacement
of a single indole group with another aromatic group is less
likely to introduce a major perturbation of the protein's
structure.
We have applied the strategy of single-Trp replacement
difference spectroscopy to an analysis of the Trp environments of the extracellular domain of human tissue factor
(TF). Soluble TF (sTF) contains four Trp residues, several
of which are in functionally important regions (Rehemtulla
et al., 1992; Ruf et al., 1992a,b, 1994). The full-length
parent protein is a 263-residue, membrane-bound glycoprotein that has an essential role in the initiation of blood
coagulation (Bach, 1988; Nemerson, 1988; Edgington et al.,
1991). In addition to the extracellular domain (residues
1-219), TF includes a single transmembrane domain (residues 220-242) followed by a short cytoplasmic tail (residues 243-263) (Spicer et al., 1987). After tissue damage,
the extracellular domain of TF binds to coagulation factors
VII and VIIa, both of which circulate in the blood. Formation of the complex with TF is essential for the proteolytic
activity of VIIa, and this procoagulant proteolytic activity is
the best index of TF function. The truncated form of TF,
sTF, prepared in our laboratory contains the first 218 residues of the extracellular domain, and it forms a high affinity
complex with VIIa (Waxman et al., 1992, 1993a). Although
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sTF lacks the transmembrane and cytoplasmic portions of
the native molecule, in the presence of phospholipids it
retains procoagulant activity (Waxman et al., 1992; Neuenschwander and Morrissey, 1992; Fiore et al., 1994).
To carry out a spectroscopic analysis of the local environments of the four Trp residues in sTF, we prepared a set
of Trp-to-Phe or Trp-to-Tyr single replacement mutants of
sTF. To evaluate perturbations of protein structure caused
by mutation, stability against denaturation in guanidinium
chloride (Gdm.Cl) was measured. To evaluate function,
mutant sTF:VIIa binding affinities and proteolytic activities
were measured. The features of the local environments of
the Trp residues were then deduced from the difference
spectra of the mutants versus the wild-type protein. Finally,
to assess the validity of this approach, the results of the
spectroscopic analysis were compared with information
about the local environments of the individual Trp residues
obtained from the x-ray crystal structure of the 219-residue
extracellular domain of human TF determined by Harlos et
al. (1994).

MATERIALS AND METHODS
Reagents
Human recombinant VIla was purchased from NOVO Nordisk (Denmark), and factor X was purified from human plasma by methods of
Miletich et al. (1981) and Broze and Majerus (1980). The concentration
of X was determined by using an A17(l cm) of 11.6 at 280 nm (Di Scipio
et al., 1977). Purified factor Xa was prepared by Dr. H. Andree. The
chromogenic substrate for Xa, Ile-Pro-Arg-p-nitroanilide (IPR-pNA)
was synthesized by Dr. G. Schwartz. VII-deficient plasma was prepared
in our laboratory by using an immunoadsorption anti-VII Affigel-10 column to remove factor VII. Thrombofax was purchased from Ortho Diagnostic System (Raritan, NJ). 1,2-Dioleoyl-sn-glycero-3-phosphatidylserine
(DOPS) and 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) were
obtained from Avanti Polar Lipids (Alabaster, AL). Guanidinium chloride
was purchased from Heico Chemicals (Delaware Water Gap, PA). Endoproteinase Lys-C was obtained from Boehringer Mannheim (Indianapolis,
IN). Restriction enzymes were from New England Biolabs (Beverly, MA).

Mutation of the tryptophan residues in sTF
Construction of the vector for bacterial expression of sTF, p6TF219, is described elsewhere (Waxman et al., 1992; W. H. Konigsberg, J. B. A. Ross, A.
Guha, S. V. Thiruvikraman, C. Fang, and Y. Nemerson, submitted for publication). The following oligonucleotides were used for Trp mutations in the
expression vector p6TF219; the triplet base changes coding for Phe or Tyr are
in lowercase, the new restriction cleavage sites are underlined, and the corresponding restriction enzyme is given in parentheses after each sequence: (1)
Trp-14 to Phe-14 (W14F), 5'-GGCAGCATATAATITAACTmt AAATCAACTAATTTC-3' (Dral); (2) Trp-45 to Phe-45 (W45F), 5'-CAAATAAGCACTAAGTCCGGAGATttcAAAAGCAAATGCITI-3' (BstBI); (3) Trp158 to Phe-158 (W158F), 5'-aITAATfrATACACTATTATtttAAATCTTCAAGTTCAGG-3' (Dral); and (4) Trp-25 to Tyr-25 (W25Y), 5'-

CTAATTCAAGACAA1TCrCGAGtacGAACCCAAA CCCOGTC-3' (XhoI).

Expression, purification, and confirmation of sTF and
mutants
The plasmids, transformed into Escherichia coli strain BL-21 (DE-3), were
grown in a 2-L Virtis fermenter at 37°C in DE-3 media (40 mM Na2HPO4,
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20 mM KH2PO4, 10 mM NaCl, 0.1 M NH4Cl, glycerol (25 g/L), and
tryptone (10 g/L)), with added oxygen and maintenance of pH at 7.4, for
approximately 6 h. After induction with 1 mM (final concentration) isopropyl-D-thiogalactopyranoside, the cells were allowed to grow for 16 h at
room temperature. Protein from the media was purified and characterized
as described (Waxman et al., 1992). The Trp mutations were checked by
high pressure liquid chromatography peptide mapping after digestion with
Endolys-C. Peptides containing the mutated residues were identified on the
basis of their absorption spectra obtained on-line during the high pressure
liquid chromatography and confirmed by amino acid sequence analyses.
Criteria for protein purity was by Coomassie-stained polyacrylamide gel
electrophoresis and by linear combination of spectra analysis of the absorbance spectra (Waxman et al., 1993b).
Using the fermentation procedure described above, under optimal
circumstances we have been able to produce >50 mg/L media of
purified wild-type sTF. Typical yields during the course of these
experiments were - 15 mg/L media, which represents a significant
improvement over protein expression by culture in shaker flasks. Also,
it facilitates protein purification because most of the protein in the
culture media is sTF. Yields of the mutants were variable. The yield of
W158F was equivalent to sTF, whereas that of W45F was approximately one-half that of sTF. The yield of W14F was an order of
magnitude less than that of sTF (-2 mg/L media), and using both
fermenter and shaker flask culture protocols we were unable to express
sufficient W25F (Trp-25 to Phe-25) for purification. However, W25Y
was expressed in sufficient amounts (-2 mg/L media) for characterization by absorption and fluorescence spectroscopy.

Cofactor activity assay of sTF and mutants
We previously have shown that the association of sTF with VIIa yields a
1:1 stoichiometric complex with an equilibrium dissociation constant of
-1 nM (Waxman et al., 1992). In the following, we refer to both sTF and
the mutants as cofactor. To compare the apparent dissociation constants
and relative catalytic efficiencies of sTF and sTF mutants with VIIa, we
titrated Vlla over a range of cofactor concentrations from 0 to 2 ,uM and
monitored the cofactor:enzyme complex by its ability to convert X to Xa.
An automated robotic system, developed by our laboratory, was used to
perform this assay. Briefly, cofactor was added to a solution of VIIa
(1 nM), X (100 nM), and Ca21 (5 mM); (final concentrations) in HEPESbuffered saline with bovine serum albumin (BSA), containing 10 mM
HEPES, 0.14 M NaCl, 1 mg/ml BSA, pH 7.5. After 5 min equilibration
of the 285-,Lp sample at 25°C, conversion of X to Xa was initiated
by addition of 15 ,uL of 0.2 mM DOPS/DOPC phospholipid vesicles
(30/70 w/w; final phospholipid concentration of 10 ,uM). At 30-s intervals,
20-,uL aliquots were withdrawn and transferred to microtiter wells that
contained 125 pLL of 50 mM EDTA in HEPES buffered saline with BSA
to terminate conversion of X to Xa. Then the chromogenic substrate
IPR-pNA was added to a final concentration of 1.5 mM. The amount of Xa
produced at each time point was determined by measuring the rate of
hydrolysis of IPR-pNA; the slope of the initial absorbance increase at 405
nm versus time, calculated by linear regression, was proportional to the Xa
concentration. The amount of Xa produced by the different complexes was
determined by comparison to a standard curve of IPR-pNA hydrolysis at
known concentrations of purified Xa.
A particular mutation can change the binding of cofactor to VIIa. It can
also change the enzymatic activity of the complex. These effects are
described by the apparent equilibrium dissociation constant for the cofactor:VIIa complex and the maximum velocity for conversion of X to Xa,
respectively. (The underlying assumption is that X binding is essentially
equivalent for all cofactor:VIIa complexes and therefore does not affect
their apparent dissociation constants. We point out that this assumption is
implicit in all studies using X activation to evaluate TF:VIIa interactions.)
An apparent dissociation constant for each cofactor:VIIa complex was
determined by measuring VIIa activity at increasing concentrations of
cofactor and at a saturating concentration of the substrate X. The VIIa
concentration was 1 nM, near that of the dissociation constant for the

complex of unmodified sTF and VIIa, previously determined by pressure
perturbation (Waxman et al., 1992). In this situation, the observed velocity,
VObS, as a function of cofactor concentration, reflects directly the concentration of cofactor:VIIa complex:

Vob. =

[cofactor:VIIa]kca,*

(1)

A maximum velocity, Vm, cofactor' is achieved in the titration when VIIa is
saturated with cofactor, i.e., sTF. This leads to an expression that defines
the equilibrium concentration of the VIIa:cofactor complexes in terms of
the observables, such that

[cofactor:VIIa]=
where
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V0bs

[Vmax cofactorJ

[VIIao],

(2)

terms of the apparent Stern-Volmer constant, Ksv, calculated from the
equation

FO/F= 1 + Ksv[Q],

n

I aliTi2

stants, Kd, were obtained by fitting the titration data by least squares using
the appropriate root of the quadratic equation

+

[cofactorj]) + [VIIao][cofactoro] = 0,(3)

where [cofactor0] is the total cofactor concentration at each point in the
titration. Comparison of Vm, cofactor Of each mutant to Vm,,, TF reflects
directly the catalytic efflciencies of the complexes. These titrations do not
reveal potential changes in Km of the complex for substrate X because the
substrate concentration was both constant and saturating; thus changes in
k,t are determined simply, without elaborate kinetic analysis.

Ultraviolet absorption, circular dichroism, and
fluorescence spectroscopy
Unless otherwise noted, spectroscopic measurements were made by using
0.1 M NaCl, 0.05 M Tris, pH 7.5, buffer. Absorption spectra were measured at room temperature with a dual-beam Hitachi U-3210 spectrophotometer. Molar extinction coefficients were determined for sTF and mutants by diluting and denaturing an aliquot of each sample stock in 6 M
Gdm Cl and measuring the spectra. The concentration of denatured protein
was then calculated from knowledge of the protein's Trp and Tyr content
and the Beer-Lambert law, by using a value of 5500 M-1cm-1 for the
280-nm extinction coefficient of Trp (Wetlaufer, 1962) and by using the
relative, scaled 280-nm extinction coefficient of Tyr obtained from Trpand Tyr-containing peptides in 6 M Gdm-Cl as described previously
(Waxman et al., 1993b). The dilutions then provided the appropriate factors
for calculating the scaled molar extinctions and the concentrations of the
native proteins.
Unfolding as a function of GdmnCl concentration was used to assess the
structural stabilities of the mutants relative to sTF at pH 7.5 with either
50 mM Tris (fluorescence) or 5 mM phosphate (circular dichroism (CD))
at 24°C. To eliminate kinetic contributions as a result of the unfolding
process, the solutions were equilibrated overnight before measurement. CD
spectra of samples in 0.2-cm-path-length cells were obtained by using a
Jasco J-500A circular dichroism spectrophotometer. The mean residue
ellipticity was calculated by using a molecular weight of 24,672, based on
the amino acid composition of sTF. Steady-state fluorescence emission
spectra (8-nm excitation and emission bandpasses) were obtained with an
SLM Aminco SPF 500C spectrofluorometer or an SLM 4800 spectrofluorometer modified in our laboratory for photon counting. To avoid emission intensity artifacts caused by molecular motions that occur during the
lifetime of the excited state, magic angle polarization conditions were used
for all fluorescence measurements (Badea and Brand, 1979). To minimize
the contribution of Tyr residues to emission spectra, 295-nm excitation was
used, except where indicated.
Fluorescence quenching by KI at high ionic strengths (0.5-0.6 M) was
used to assess solvent accessibility of emissive Trp residues. The average
solvent accessibility of the fluorescent Trp residues was characterized in

(4)

where F. is the fluorescence intensity in the absence of quencher, F is the
fluorescence intensity in the presence of quencher, and [Q] is the quencher
concentration (see Lakowicz, 1983). For the case for which it is known that
the fluorescence is caused by a single emitter with multi-exponential
intensity decay kinetics and there is no ground-state quenching interaction
introduced by the quencher (see below), the observed Ksv is the product of
the bimolecular collisional quenching constant, kq, and the mean (intensity
average) fluorescence lifetime of the emitter in the absence of quencher,
(T.), is defined by the equation

[VITa0] is the total VIIa concentration. Apparent dissociation con-

[cofactor:VIIa]2 - [cofactor:VIIa](Kd + [VIIao]

July 1995

i=l

(T.)=

n

(5)

i=l

where a1 is the amplitude and Tr is the lifetime of the ith emitting
component (see Laws and Contino, 1992; Eftink, 1991). Mean lifetimes
were obtained for mutants identified as single Trp emitters by the timecorrelated single-photon counting method (see Hasselbacher et al., 1991) at
a resolution of 22.3 ps per data point distributed over 2000 points.
Quenching interactions are operationally defined as dynamic or static,
according to the kinetic signature of the fluorescence intensity decay
compared with the steady-state fluorescence quantum yield. Dynamic
quenching reflects an interaction that occurs during the lifetime of the
excited state of a fluorophore. Static quenching indicates that, while in the
ground state, some fraction of the fluorophores is involved in an interaction
that causes that fraction to be nonemissive after excitation by a photon.
Although both mechanisms result in a reduction of the steady-state fluorescence intensity, only dynamic quenching results in a reduction of the
fluorescence lifetime. For a more detailed discussion, see Lakowicz (1983).

RESULTS AND DISCUSSION
Effects of single Trp replacements in sTF on
cofactor activation of Vila
We compared the cofactor activities of sTF and the Trp
mutants as described in Materials and Methods. In these
experiments, kcat for the sTF:VIIa complex was 4 min-',
which is in the range that we observed previously (Waxman
et al., 1992). Under the assay conditions, the catalytic efficiency as a function of cofactor concentration reflects the
degree of saturation of VIIa by cofactor. This yields apparent dissociation constants, which are listed in Table 1. For
mutant cofactor concentrations at which Vlla is saturated,
we obtain a direct measure of the catalytic efficiencies of
the cofactor:VIIa complexes, which are also listed in Table
1. Mutant W14F is comparable with sTF in both binding
and conferring catalytic activity to VIIa. The binding affinity between W158F and VIIa also is in the 2 nM range, and
the maximal catalytic activity is approximately one-half that
of the sTF:VIIa complex. W25Y binding to VIIa is approximately one-fourth that of sTF, but the complex has nearly
the same activity as that observed with sTF. Although
W45F displays the weakest association with VIIa, approximately an order of magnitude weaker than sTF, the com-
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TABLE I Apparent equilibrium dissociation constants and
relative catalytic rate constants for the mutant and wild-type
sTF complexes with Vila

L,2
E
N

Cofactor

Kd (nM)

kt (min')

E
0

sTF
W14F
W25Y
W45F
W158F

2
2
7
20
2

4.0
4.0
3.2
2.4
2.4

0)

Apparent equilibrium dissociation constants (estimated uncertainty, Kd
2 to Kd X 2) and relative catalytic efficiencies (estimated uncertainty,
±20%) of the cofactor: Vlla complexes at 25°C measured by chromogenic
assay as described in Materials and Methods.

plex still has approximately one-half the catalytic activity as
that observed with sTF. The binding and activity of W45Y
is identical to W45F (data not shown).
The reduced affinities of W25Y and W45F for VIIa
indicate that these residues themselves are either involved in
interaction with Vlla or that replacement of the indole ring
with the smaller phenol ring or phenyl ring alters the packing constraints of other surface residues that form contacts
with VIIa. Nevertheless, once formed, the cofactor:VIIa
complexes are all functional. As the essential catalytic efficiency of VIIa results from binding of its cofactor, the
twofold or smaller differences in catalytic efficiencies observed here suggest that when the Trp mutants are bound to
VITa they have structures that are very similar to that of the
wild-type protein.

Stabilities of sTF and mutant proteins
As pointed out by Eftink (1994), Trp located at different
locations within a protein will not necessarily give identical
reports about the protein unfolding process as the local
environments of each Trp may not be equally resistant to
denaturation. As described below, the fluorescence emission of sTF, W14F, W25Y, and W158F is caused mainly by
Trp-45 and therefore the initial changes in the emission
spectra of these proteins that result from unfolding mainly
report on the stability of the environment of Trp-45. Also as
described below, the initial change in the fluorescence spectrum of W45F reports mainly on the stability of the local
environment of Trp-14, as that is the dominant emitter in
this mutant. Therefore, CD, which measures global changes
in secondary structure, was used also to evaluate stability as
well as refolding.
An example of the effect of Gdm Cl upon the CD spectrum is shown for sTF in Fig. 1. It should be noted that the
ultraviolet CD of native sTF for the region between 210 and
250 nm is similar to that reported previously by Ruf and
Edgington (1991), who interpreted the CD in terms of a
secondary structure composed of 62-65% (3-strand, 2325% random coil, and 11-13% (-turn. The characteristic
feature in the region between 210 and 250 nm is a prominent band with positive ellipticity centered near 232 nm.
There is also a weaker negative band in the region near 280

00

x
CD

-4

-

240
265
290
wavelength (nm)

215

315

FIGURE 1 The change in the CD spectra of sTF as a function of Gdm-Cl
concentration: -, 0 M; ...., 1.25 M; ----, 1.5 M; -.-, 2.7 M.

nm, indicated by the inset in Fig. 1, for which the absorbance is dominated by the aromatic rings of Tyr and Trp.
Both features disappear upon denaturation in Gdm-Cl and,
within experimental error, the changes in the CD spectra are
consistent with the changes in the fluorescence spectra.
Upon removal of Gdm Cl by dialysis, the native CD spectrum is recovered, indicating that unfolding of sTF in
Gdm Cl is reversible.
Whereas the emission intensity of W45F increases upon
denaturation in Gdm Cl (Fig. 2A), the emission intensities of
the other proteins, including W14F, decrease (Fig. 2B;
shown for sTF). This behavior indicates that the different
Trp residues have different quantum yields in the native
state. Nevertheless, the centers of gravity of the fluorescence emission spectra of sTF and all the mutants shift to
the red upon denaturation in Gdm Cl, consistent with exposure of the Trp residues to solvent. At approximately 2 M
Gdm Cl and with 295-nm excitation, the emission maxima
of all of the proteins are coincident with that of N-acetyltryptophanamide (NATA) under the same conditions. As
shown in Fig. 3, one-half of the maximal shift in the
fluorescence spectrum of sTF occurs at -1.5 M Gdm-Cl.
The half-maximal shift in the spectra of the mutants occurs
between 1.1 and 1.2 M Gdm Cl.
Each of the mutants exhibit reduced stabilities compared
with sTF, indicating that each of the Trp indole groups are
involved in intramolecular interactions that help to stabilize
the protein structure. The emission shifts and changes in the
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FIGURE 2 Fluorescence emission spectra as a function of Gdm Cl concentration of W45F mutant (A) and sTF (B). (A) -, 0 M; ----, 1.1 M; ..., 1.2
M; -.-, 3.0 M. (B)-, 0 M;.,1.5 M; -.-, 3.0 M.
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fluorescence intensities of sTF and the four mutants in
Gdm Cl reflect the loss in the denatured state of specific
indole ring interactions in each Trp environment. Also, it
should be noted that the emission spectra of W45F obtained
at different Gdm Cl concentrations exhibit an isoemissive
point (Fig. 2A). This is consistent with a two-state process
for the unfolding of W45F. Moreover, the denaturation
progress curves of W14F and W158F are essentially indistinguishable from that of W45F (Fig. 3), which suggests that
their unfolding proceeds in the same fashion and that their
three Trp residues report identically the same pathway of
unfolding. In contrast, the denaturation curve of W25Y is
intermediate between those for the other mutants and sTF.
Compared with the other proteins, denaturation of W25Y
proceeds over a broader range of Gdm-Cl concentrations,
suggesting that unfolding of this mutant is different and that
one or more of the three remaining Trp residues is reporting
a change in unfolding pathway resulting from replacement
of Trp-25.

Resolved absorbance spectra of the individual
tryptophan residues in sTF
The absorption spectrum of each protein was obtained for
the wavelength region 260-340 nm, as described in Materials and Methods. The individual spectrum of each Trp was
then calculated for the wavelength range 270-320 nm (to
exclude significant absorption from Phe residues) by subtraction of each mutant protein spectrum (three Trp residues) from that of sTF (four Trp residues). It should be
noted that three of the mutants, W14F, W45F, and W158F,
and sTF itself contain the same number of Tyr residues. In
this way, we resolved the spectra of Trp-14, Trp-45, and
Trp-158 (Fig. 4). However, as described in Materials and
Methods, W25F did not express well. Therefore, calculation
of the spectrum of Trp-25 required the use of mutant W25Y.
This situation made it necessary to account for an additional
Tyr residue in the mutant.
Because the absorbance of this Tyr residue in the
folded protein could not be resolved directly, the assumption was made that its absorption could be adequately
represented by the number average absorption of all 12
Tyr residues in the mutant. The total Tyr absorbance of

290

310

270

290

310

wavelength (nm)
FIGURE 4 Comparison of normalized absorbance spectra of the four
Trp in sTF (-) with that of NATA in aqueous buffer --- -) and in dioxane

W25Y was obtained by subtracting the absorption contributions of Trp-14, Trp-45, and Trp-158, calculated
from the other three mutants, from the spectrum of
W25Y. The difference spectrum obtained by this procedure had an absorption maximum at 278 nm, characteristic of Tyr, and showed no obvious contribution from
Trp. This result indicates that the resolved Trp spectra
obtained from the other three mutants represent accurate
estimates of the absorption contributions of Trp-14, Trp45, and Trp-158 in W25Y. The number average (1A2) of
the calculated Tyr spectrum was subtracted from that of
W25Y and the resulting spectrum was subtracted from
that of sTF, generating the spectrum attributed to Trp-25,
shown in Fig. 4. It should be noted that the difference
spectrum of trp-25 in Fig. 4 is negative in the region
>300 nm and returns to zero at 310 nm. The negative
deflection, which represents 10% of the total normalized
Trp difference spectrum, probably reflects error from
using the number average Tyr absorbance to estimate the
absorbance for the Tyr residue introduced at position 25.
This is no surprise as it is known that the absorbance of
Tyr residues depend upon the local environments (Wetlaufer, 1962; Ross et al., 1992a). However, as the negative base line deflection could be eliminated by rescaling
the calculated Tyr absorption, and this procedure does
not affect significantly either the positions or resolution
of the Trp-25 difference spectrum, we conclude that the
base line error does not alter in any substantial way the
conclusions drawn from the difference spectrum generated for Trp-25.
The individual Trp absorption spectra in Fig. 4 are
compared with those of NATA in aqueous buffer, which
models a protein-bound Trp exposed to polar medium,
and NATA in dioxane, which models a Trp residue
buried in the protein interior. All four difference spectra
are red-shifted compared with NATA in aqueous buffer.
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This suggests that the four Trp in the native protein are
not fully exposed to the aqueous solvent. In addition, the
spectra of Trp-14 and Trp-25 show greater resolution of
the characteristic vibronic band of the 1¾, electronic
transition of indole that occurs near 290 nm (Strickland et
al., 1971; Valeur and Weber, 1977). Greater resolution of
the electronic transitions, as a result of narrower vibrational bands, generally reflects a smaller distribution of
interactions with the neighboring chemical groups in the
local environment of a Trp residue (Ross et al., 1980).
This could result from greater packing restrictions for the
indole rings of Trp-14 and Trp-25 compared with those
of Trp-45 or Trp-158.

Fluorescence emission spectra of the Trp
residues in sTF
With excitation at 295 nm, the intensities and shapes of the
steady-state fluorescence spectra of W25Y and W158F are
identical within experimental error to that of sTF, shown in
Fig. 5A. This indicates that Trp-25 and Trp-158 do not
fluoresce. By contrast, the emission intensities of both
W14F and W45F are weaker than that of sTF; according to
the integrated spectra, W14F accounts for 73 ± 3% and
W45F accounts for 23 ± 1% of the total steady-state fluorescence yield of sTF. Thus, the fluorescence emission of
sTF can be accounted for by the combined yields of W14F
and W45F, indicating that Trp-14 and Trp-45 are the dominant emitters in sTF, as shown in Fig. 5A. This result also
indicates that the emission spectrum of W45F is due to
Trp-14 and that of W14F is due to Trp-45. Because
Rayleigh scattering caused by the protein distorts the
high energy side of the emission spectra, the spectra are
not accurately representative of these two Trp residues.
Assuming that the Rayleigh scattering contributions of
the mutant and wild-type proteins are identical, more
accurate representations can be obtained by subtraction
of the mutant spectra from that of the wild-type protein.
Based on the relative quantum yields of W14F, W45F,
and sTF, the difference fluorescence spectra from W14F
and W45F are expected to correlate, respectively, with
the resolved emission contributions from Trp-14 and

25

Trp-45. These assigned difference spectra are shown in
Fig. 5B. Accordingly, the emission spectrum of Trp-14
closely resembles that of NATA in dioxane, and the
spectra of both Trp-14 and Trp-45 are blue-shifted compared with that of NATA in neutral pH aqueous buffer.
These features of the fluorescence difference spectra
indicate that neither residue side chain is fully exposed to
the aqueous solvent, consistent with the absorption difference spectra.
Solvent accessibility of the emitting Trp residues of sTF
and the mutants was further assessed by quenching of the
fluorescence emission. As expected from the close similarity of the fluorescence emission spectra and intensities of
sTF, W25Y, and W158F, the fluorescence quenching behaviors of these three proteins were similar. This is consistent with the conclusion that Trp-25 and Trp-158 have
insignificant fluorescence yields compared with Trp-14 and
Trp-45. The quenching data yielded essentially linear plots
with apparent KSV values near 1.8 M-1; see Eq. 4. By
contrast, W45F showed significantly less quenching with a
KSV value of -0.2 M-1, and W14F exhibited more quenching with a KSV value of 2.4 M-1. On the basis that the main
emitter in W45F is Trp-14 and the main emitter in W14F is
Trp-45, the relative exposures of these two Trp residues can
be compared directly in terms of their bimolecular quenching constants (kq). From mean lifetimes of 2.2 ns for W45F
and 5.9 ns for W14F, the calculated kq values are 9 X 107
M-1 s-1 for Trp-14 and 4 X 108 M s-for Trp-45. For
comparison, NATA, with a fluorescence lifetime of 3.0 ns
and a KSv value of 10.5 M-1, has a kq value of 3.5 X 109
M-1 s-1, which is close to that expected for unhindered
diffusion. Thus, the quenching results support the absorption and fluorescence spectra and together indicate strongly
that Trp-14 and Trp-45 are largely buried and have limited
exposure to solvent; Trp-14 is the more buried residue
because it has the more blue-shifted emission spectrum and
the smaller bimolecular quenching constant (cf. Eftink,

1991).
It is noteworthy that the fluorescence emission intensity of
W158F, when measured with 280-nm excitation, is greater
than that of sTF, and the resulting difference emission spectrum has a maximum at -310 nm (Fig. 6). This difference
spectrum is characteristic of Tyr, and it suggests that in sTF the
fluorescence of one or more nearby Tyr residues are quenched
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FIGURE 5 Fluorescence emission spectra of sTF (-), W14F (- - -), and
W45F ( .) at 3 ,uM. (B) Normalized fluorescence emission spectra of
Trp-14 (-.-) and Trp-45 (-) as compared with NATA in aqueous buffer
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FIGURE 6 Fluorescence difference spectrum between W158F and sTF
excited at 280 nm.
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by resonance energy transfer to Trp-158. There are three nearneighbor Tyr residues in the primary structure surrounding
Trp-158 that could be potential excitation energy donors. It is

also possible, however, that the donors could be other Tyr
residues that are near Trp-158 as a result of the tertiary structure of the folded protein.
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Trp-45. (B) View of domain 2 showing Trp-158.
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Evaluation of the spectroscopy results in terms of
the crystal structure of sTF
As recently described, the crystal structure of the extracellular region of tissue factor comprising the first 219 residues
has now been solved (Harlos et al., 1994; see also Muller et
al., 1994). sTF consists of two seven-stranded ,B-sandwich
immunoglobulin-like domains (1 and 2) joined by an extensive novel midriff region. A MOLSCRIPT representation (Kraulis, 1991) of sTF is shown in Fig. 7. This is a
graphical representation of the secondary structure in three
dimensions. It shows residues 3-213 (the first two and the
last six were disordered). For clarity and reference purposes,
the region implicated in binding VIIa (Ruf et al., 1994;
Muller et al., 1994) has been colored yellow, whereas the
region in domain 2 near the phospholipid surface and implicated in factor X activation (Roy et al., 1991; Ruf et al.,
1992a,b) has been colored red. The four Trp residues have
been highlighted in ball-and-stick format and labeled. The
solvent accessibilities of the four Trp residues have been
calculated with the use of the Dictionary of Secondary
Structure Prediction (Kabsch and Sanders, 1983).
When compared with a solvent accessibility area of 340350 A2 for a solvent-exposed indole side chain, Trp-14 and
Trp-25 are essentially buried residues. They have solvent
accessibility areas of -39 and 16 A2, respectively, and they
form part of the hydrophobic core of domain 1; both residues are in restricted environments (Fig. 8A). By contrast,
Trp-45 has a significantly larger solvent accessibility area of
86 A2 for its indole side chain. According to the fluorescence emission spectra and fluorescence quenching with
iodide ion, Trp-14 is more buried than Trp-45, and both
residues are largely shlelded from solvent, as is evident
from the crystal structure model. Trp-158, however, with a
solvent-accessible area of 41 A2, has a limited solvent
exposure, similar to Trp-14. As shown in Fig. 8B, the indole
ring of Trp-158 is lying on the protein surface but is not
projecting into solvent. It lies partially exposed on the end
of a strand in domain 2, and it is in the middle of a region
implicated in factor X binding (Roy et al., 1991; Ruf et al.,
1992a,b). Based on the nearly equivalent solvent exposure
of the indole side chains of Trp-14 and Trp-158, one might
expect their absorption spectra to be more similar. It is
possible, however, that the less resolved vibrational bands
of the Trp-158 absorption spectrum reflect solvent interactions with different regions of the indole ring. Tyr-153,
Tyr-156, and Tyr-157 are residues close in primary sequence to Trp-158, which might account for the appearance
of the additional Tyr emission in the fluorescence of
W158F. Any or all of these Tyr residues could be quenched
by resonance energy transfer to Trp-158 in sTF. In addition,
it should be noted that, as a result of folding in the tertiary
structure of sTF, the phenol ring of Tyr-185 is within 10 A
of the indole ring of Trp-158, which is close enough for
quenching the fluorescence of this Tyr residue by resonance
energy transfer to Trp-158 (see Tyr difference emission
spectrum of W158F in Fig. 6). The efficient quenching of
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Trp-158, making it nonfluorescent, could result from interaction with the ammonium group of Lys-165, which, in the
crystal structure, lies 3-5 A from the face of the indole ring.
As shown by Barkley and co-workers (Yu et al., 1992),
ammonium groups are efficient quenchers. Lys-165 is part
of a flexible loop, and increased mobility could enhance the
possibility of quenching by the protonated Lys e-amino
group. A second candidate that could account for the
quenching of Trp-158 is the disulfide bridge formed between Cys-186 and Cys-209; atom C62 of the Trp-158
indole ring is 4.05 A from atom S,, of Cys-186; as discussed
by Ross et al. (1992b), the quenching by a proximal disulfide could occur as a result of resonance energy transfer, as
there is overlap between the disulfide absorption and Trp
fluorescence. Similarly, Trp-25, the other nonfluorescent
residue, could be quenched by the other disulfide bridge
formed by Cys-49 and Cys-57. Atoms C, and Co of the
Trp-25 indole ring are 5.4 and 5.46 A, respectively, from the
nearest disulfide sulfur, SI, of Cys-57. These observations
from the crystal structure support entirely the interpretations
of Trp fluorescence from the difference spectroscopic measurements.
In summary, the conclusions from solution measurements
with difference absorption and fluorescence spectroscopy,
based on functionally active single-Trp replacement mutants, are in excellent agreement with solvent accessibility
areas calculated from the crystal structure model of sTF.
Moreover, the fluorescence properties of the individual Trp
residues can be accounted for readily by the crystal structure
model. Thus, in the absence of an x-ray crystal structure
model, we anticipate that information about individual Trp
environments, even in multi-Trp proteins, can be obtained
by similar solution measurements. For example, we anticipate that resolved Trp spectra, obtained by this approach,
should provide more direct information about conformational transitions that result from binding of ligands or from
reversible modifications, such as phosphorylation, which
are important in the regulation of cellular processes.
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